Related Experiment Videos
Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain
Sandra R Chaplan1, Hong-Qing Guo, Doo Hyun Lee
1Neuroscience, Johnson & Johnson Pharmaceutical Research and Development, San Diego, California 92121, USA. schaplan@prdus.jnj.com
Summary
Hyperpolarization-activated, cyclic nucleotide-modulated (HCN) channels are crucial in neuropathic pain. Blocking these channels in nerve injury models reduces pain sensitivity and abnormal nerve firing, offering new therapeutic avenues.
Area of Science:
- Neuroscience
- Pain Research
- Molecular Biology
Background:
- Neuropathic pain is a debilitating condition with limited treatment options.
- It often results from nerve damage due to various causes like trauma, infections, or chemotherapy.
- Spontaneous firing of injured nerves is a key factor in neuropathic pain development.
Purpose of the Study:
- To investigate the role of hyperpolarization-activated, cyclic nucleotide-modulated (HCN) channels in neuropathic pain.
- To explore HCN channels as potential therapeutic targets for pain relief.
Main Methods:
- Utilized a rat nerve ligation model to study neuropathic pain.
- Examined the expression and function of HCN channels in dorsal root ganglion (DRG) neurons.
- Administered the specific HCN channel inhibitor ZD7288 to assess its effects on pain behaviors and neuronal activity.
Main Results:
- Nerve injury significantly increased pacemaker currents in large-diameter DRG neurons.
- HCN channels, particularly HCN1, are highly expressed in primary afferent somata.
- ZD7288 treatment reversed hypersensitivity to light touch and reduced ectopic discharge frequency in Abeta and Adelta fibers.
- These effects were achieved without causing conduction blockade.
Conclusions:
- HCN channels play a previously unrecognized role in mediating touch-related pain and spontaneous neuronal discharge after nerve injury.
- Targeting HCN channels with specific inhibitors like ZD7288 shows promise for developing novel and effective neuropathic pain therapies.